Rocket Pharmaceuticals RCKT Insider Ownership

Updated Oct 21, 2026

Over the trailing 12 months, RCKT insiders bought $34,400 worth of shares (10K shares) and sold $864,004 worth (258.04K shares) in open-market trades.

• Rocket Pharmaceuticals' open-market purchases in the past 12 months came from one insider, and its sales from 6 insiders.
• Among Rocket Pharmaceuticals' insiders, Elisabeth Bjork (Director) was the largest open-market buyer over the past 12 months, purchasing $34,400 of stock (10K shares), most recently on January 2, 2026.
• Meanwhile, the largest open-market sales of RCKT in the past 12 months were by Martin Wilson (General Counsel), totaling $334,607 (98.79K shares), most recently on September 11, 2026.
• In transactions other than open-market trades, Rocket Pharmaceuticals insiders received 1.04Mn shares in stock awards and acquired 76.49K shares through option exercises and conversions over the past 12 months.
• Business Quant data puts insider holdings in RCKT at 23.37Mn shares across insiders' latest Form 4 filings, or 20.71% of the 112.84Mn shares outstanding.
• Direct holdings account for 4.52Mn shares (19.35%) of RCKT's insider total, and indirect holdings through trusts, partnerships and family members for 18.85Mn shares (80.65%).
• Per Business Quant, 21 insiders of RCKT hold shares, counting officers, directors and 10% owners who have filed a Form 4 in the past two years.
• RCKT's largest insider holders by reported holdings are RTW Investments, LP (Director and 10% owner, 18.19Mn shares), Gaurav Shah (CEO, 1.06Mn shares) and Martin Wilson (General Counsel, 598.49K shares).
• Of the shares held by RCKT insiders, 77.82% belong to RTW Investments, LP.
• Over the past 12 months, 14 insiders reported transactions in Rocket Pharmaceuticals stock in 42 Form 4 filings.
• The insider holdings and trades above for Rocket Pharmaceuticals reflect Form 4 filings through September 15, 2026.